Risk score model for fatal intracranial hemorrhage in acute leukemia

Leukemia

Volumn 20, Issue 5, 2006, Pages 770-776

  Kim, H ^a   Lee, J H ^b,b   Choi, S J ^b   Seol, M ^b   Lee, Y S ^b   Kim, W K ^b   Lee, J S ^b   Lee, K H ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute leukemia; Cerebral hemorrhage; Risk

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; PREDNISONE; PROTHROMBIN; RETINOIC ACID; VINCRISTINE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEASIBILITY STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; THROMBOCYTOPENIA; VALIDITY;

EID: 33646134136     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404148     Document Type: Article

References (48)

1. Ribeiro RC, Pui CH. The clinical and biological correlates of coagulopathy in children with acute leukemia. J Clin Oncol 1986; 4: 1212-1218.
2. Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine (Baltimore) 1976; 55: 259-268.
3. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: Impact on remission rate and duration, and survival. J Clin Oncol 1987; 5: 1364-1372.
4. Visani G, Gugliotta L, Tosi P, Catani L, Vianelli N, Martinelli G et al. All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia. Eur J Haematol 2000; 64: 139-144.
5. Frankel SR, Eardley A, Heller G, Berman E, Miller Jr WH, Dmitrovsky E et al. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Ann Intern Med 1994; 120: 278-286.
6. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T et al. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Blood 1995; 85: 1202-1206.
7. Estey E, Thall PF, Pierce S, Kantarjian H, Keating M. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. J Clin Oncol 1997; 15: 483-490.
8. Pochedly C. Neurologic manifestations in acute leukemia. I. Symptoms due to increased cerebrospinal fluid pressure and hemorrhage. NY State J Med 1975; 75: 575-580.
9. Creutzig U, Ritter J, Budde M, Sutor A, Schellong G. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia. Cancer 1987; 60: 3071-3079.
10. Di Bona E, Avvisati G, Castaman G, Luce Vegna M, De Sanctis V, Rodeghiero F et al. Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. Br J Haematol 2000; 108: 689-695.
11. Higuchi T, Shimizu T, Mori H, Niikura H, Omine M. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia. Hematol Oncol 1997; 15: 209-217.
12. Kim H, Lee JH, Choi SJ, Kim WK, Lee JS, Lee KH. Analysis of fatal intracranial hemorrhage in 792 acute leukemia patients. Haematologica 2004; 89: 622-624.
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
14. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
15. Avvisati G, ten Cate JW, Buller HR, Mandelli F. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet 1989; 2: 122-124.
16. Groch SN, Sayre GP, Heck FJ. Cerebral hemorrhage in leukemia. Arch Neurol 1960; 2: 439-451.
17. McCormick WF, Rosenfield DB. Massive brain hemorrhage: A review of 144 cases and an examination of their causes. Stroke 1973; 4: 946-954.
18. Parma M, Casaroli I, Pogliani EM. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia. Haematologica 1996; 81: 379-380.
19. Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT. Childhood leukemia: Central nervous system abnormalities during and after treatment. Am J Neuroradiol 1996; 17: 295-310.
20. Chung CY, Hsu NC, Horng HC, Chang CS. Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia. Leukemia Lymphoma 2003; 44: 1059-1061.
21. Priest JR, Ramsay NK, Latchaw RE, Lockman LA, Hasegawa DK, Coates TD et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer 1980; 46: 1548-1554.
22. Hara T, Kishikawa T, Miyazaki S, Ishii E, Goya N. Central nervous system complications in childhood leukemia. Correlation between clinical and computed tomographic findings. Am J Pediatr Hematol Oncol 1984; 6: 129-136.
23. Feldman EJ, Arlin ZA, Ahmed T, Mittelman A, Ascensao JL, Puccio CA et al. Acute promyelocytic leukemia: A 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhage. Acta Haematol 1989; 82: 117-121.
24. Arlin ZA, Feldman EJ. Treatment of DIC associated with APL. Blood 1990; 76: 2418.
25. Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M et al. Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: Frequent complications with fibrinogen levels less than 100 mg/ dl. Leukemia Lymphoma 1996; 21: 85-92.
26. Hongo T, Okada S, Ohzeki T, Ohta H, Nishimura S, Hamamoto K et al. Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS. Japan Association of Childhood Leukemia Study. Pediatr Int 2002; 44: 293-299.
27. Tornebohm E, Blomback M, Lockner D, Egberg N, Paul C. Bleeding complications and coagulopathy in acute leukaemia. Leukemia Res 1992; 16: 1041-1048.
28. Sarris AH, Kempin S, Berman E, Michaeli J, Little C, Andreeff M et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood 1992; 79: 1305-1310.
29. Wilde JT, Davies JM. Haemostatic problems in acute leukaemia. Blood Rev 1990; 4: 245-251.
30. Ventura GJ, Hester JP, Dixon DO, Khorana S, Keating MJ. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia. Hematol Pathol 1989; 3: 23-28.
31. Park BH, Lavi E, Blank KJ, Gaulton GN. Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J Virol 1993; 67: 6015-6024.
32. Humphries JE, Hess CE, Stewart FM. Acute promyelocytic leukemia: Impact of hemorrhagic complications on response to induction chemotherapy and survival. South Med J 1990; 83: 1157-1161.
33. Jerde O. Bleeding problems in leukemia. Minn Med 1966; 49: 1457-1461.
34. Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338: 1223-1226.
35. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997; 337: 1870-1875.
36. Vahdat L, Maslak P, Miller Jr WH, Eardley A, Heller G, Scheinberg DA et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994; 84: 3843-3849.
37. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985; 3: 1590-1595.
38. Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandelli F. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 1990; 75: 2112-2117.
39. Kawakami Y, Ueki K, Chikama M, Shimamura Y, Naito T. Intracranial hemorrhage associated with nontraumatic disseminated intravascular coagulation-report of four cases. Neurol Med Chir (Tokyo) 1990; 30: 610-617.
40. Goldberg MA, Ginsburg D, Mayer RJ, Stone RM, Maguire M, Rosenthal DS et al. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 1987; 69: 187-191.
41. Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL et al. Acute promyelocytic leukemia. M.D. Anderson Hospital experience. Am J Med 1986; 80: 789-797.
42. Cordonnier C, Vernant JP, Brun B, Heilmann MG, Kuentz M, Bierling P et al. Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 1985; 55: 18-25.
43. Groopman J, Ellman L. Acute promyelocytic leukemia. Am J Hematol 1979; 7: 395-408.
44. Nilsson OG, Lindgren A, Brandt L, Saveland H. Prediction of death in patients with primary intracerebral hemorrhage: A prospective study of a defined population. J Neurosurg 2002; 97: 531-536.
45. Farley TM, Meirik O, Collins J. Cardiovascular disease and combined oral contraceptives: Reviewing the evidence and balancing the risks. Hum Reprod Update 1999; 5: 721-735.
46. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case-control study. Lancet 1996; 348: 505-510.
47. Ayala C, Croft JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 2002; 33: 1197-1201.
48. Nilsson OG, Lindgren A, Stahl N, Brandt L, Saveland H. Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 2000; 69: 601-607.